Cholangitis diagnostic criteria: Difference between revisions
Jump to navigation
Jump to search
Line 10: | Line 10: | ||
{{familytree | | |,|-|-|-|-|-|-|-|+|-|-|-|-|-|-|.| }} | {{familytree | | |,|-|-|-|-|-|-|-|+|-|-|-|-|-|-|.| }} | ||
{{familytree | | |!| | | | | | | |!| | | | | | |!| }} | {{familytree | | |!| | | | | | | |!| | | | | | |!| }} | ||
{{familytree |boxstyle=text-align: left| |B01| | | | | |B02| | | | |B03|B01='''Definitive diagnosis'''<br><br>Signs of infection and pus finding in bile during:<br>•[[ERCP]]<br>•[[PTCA]]<br>•Surgery|B02='''Charcot triad'''<br>•[[Fever]]<br>•[[Jaundice]]<br>•[[Abdominal pain]]<br><br>'''Reynold's pentad''' (includes 2 extra features)<br>•[[Sepsis]]<br>•[[Mental confusion]]|B03= '''Tokyo guidelines 2013(TG 13) '''<br><br>A.'''Systemic inflammation'''<br>A-1. Fever and/or shaking chills<br>A-2. Laboratory data: evidence of inflammatory response<br><br>B.'''Cholestasis'''<br>B-1. Jaundice<br>B-2. Laboratory data: abnormal liver function tests<br><br>C.'''Imaging'''<br>C-1. Biliary dilatation<br>C-2. Evidence of the etiology on imaging (stricture, stone, stent etc.)<br><br>Suspected diagnosis: One item in A + one item in either B or C<br>'''Definite diagnosis''': One item in A, one item in B and one item in C}} | {{familytree |boxstyle=text-align: left| |B01| | | | | |B02| | | | |B03|B01='''Definitive diagnosis'''<br><br>Signs of infection and pus finding in bile during:<br>•[[ERCP]]<br>•[[PTCA]]<br>•Surgery|B02='''Charcot triad'''<br>•[[Fever]]<br>•[[Jaundice]]<br>•[[Abdominal pain]]<br><br>'''Reynold's pentad''' (includes 2 extra features)<br>•[[Sepsis]]<br>•[[Mental confusion]]|B03= '''Tokyo guidelines 2013(TG 13) '''<br><br>A.'''Systemic inflammation'''<br>A-1. [[Fever]] and/or shaking [[chills]]<br>A-2. Laboratory data: evidence of inflammatory response<br><br>B.'''Cholestasis'''<br>B-1. Jaundice<br>B-2. Laboratory data: abnormal liver function tests<br><br>C.'''Imaging'''<br>C-1. Biliary dilatation<br>C-2. Evidence of the etiology on imaging (stricture, stone, stent etc.)<br><br>Suspected diagnosis: One item in A + one item in either B or C<br>'''Definite diagnosis''': One item in A, one item in B and one item in C}} | ||
{{familytree/end}} | {{familytree/end}} | ||
Note: | Note: ERCP= [[Endoscopic retrograde cholangiopancreatography]], PTCA =[[Percutaneous transhepatic cholangiography]] | ||
A-2: Abnormal white blood cell counts, increase of serum C-reactive protein levels, and other changes indicating inflammation<br> | A-2: Abnormal white blood cell counts, increase of serum C-reactive protein levels, and other changes indicating inflammation<br> | ||
B-2: Increased serum ALP, cGTP (GGT), AST and ALT levels. | B-2: Increased serum ALP, cGTP (GGT), AST and ALT levels. |
Revision as of 17:30, 14 December 2017
Cholangitis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Cholangitis diagnostic criteria On the Web |
American Roentgen Ray Society Images of Cholangitis diagnostic criteria |
Risk calculators and risk factors for Cholangitis diagnostic criteria |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Amandeep Singh M.D.[2]
Diagnostic criteria
Diagnosis of acute cholangitis | |||||||||||||||||||||||||||||||||||||
Definitive diagnosis Signs of infection and pus finding in bile during: •ERCP •PTCA •Surgery | Charcot triad •Fever •Jaundice •Abdominal pain Reynold's pentad (includes 2 extra features) •Sepsis •Mental confusion | Tokyo guidelines 2013(TG 13) A.Systemic inflammation A-1. Fever and/or shaking chills A-2. Laboratory data: evidence of inflammatory response B.Cholestasis B-1. Jaundice B-2. Laboratory data: abnormal liver function tests C.Imaging C-1. Biliary dilatation C-2. Evidence of the etiology on imaging (stricture, stone, stent etc.) Suspected diagnosis: One item in A + one item in either B or C Definite diagnosis: One item in A, one item in B and one item in C | |||||||||||||||||||||||||||||||||||
Note: ERCP= Endoscopic retrograde cholangiopancreatography, PTCA =Percutaneous transhepatic cholangiography
A-2: Abnormal white blood cell counts, increase of serum C-reactive protein levels, and other changes indicating inflammation
B-2: Increased serum ALP, cGTP (GGT), AST and ALT levels.